AquaBounty Technologies, Inc. (NASDAQ:AQB) Sees Significant Decline in Short Interest

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a significant drop in short interest during the month of January. As of January 30th, there was short interest totaling 17,318 shares, a drop of 25.9% from the January 15th total of 23,366 shares. Approximately 0.5% of the shares of the company are short sold. Based on an average trading volume of 39,938 shares, the short-interest ratio is currently 0.4 days. Based on an average trading volume of 39,938 shares, the short-interest ratio is currently 0.4 days. Approximately 0.5% of the shares of the company are short sold.

AquaBounty Technologies Stock Performance

Shares of AQB stock opened at $0.90 on Monday. The firm has a fifty day moving average of $0.93 and a 200-day moving average of $1.13. AquaBounty Technologies has a 52-week low of $0.50 and a 52-week high of $2.95. The stock has a market cap of $3.49 million, a price-to-earnings ratio of -1.08 and a beta of 1.28.

Institutional Investors Weigh In On AquaBounty Technologies

An institutional investor recently bought a new position in AquaBounty Technologies stock. Two Sigma Investments LP bought a new position in AquaBounty Technologies, Inc. (NASDAQ:AQB) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned approximately 0.97% of AquaBounty Technologies at the end of the most recent quarter. Institutional investors own 8.92% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of AquaBounty Technologies in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, AquaBounty Technologies currently has an average rating of “Sell”.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.